Organization of Outpatient Care After COVID-19 Hospitalization

doi:10.1016/j.chest.2022.01.034

Organization of Outpatient Care After COVID-19 Hospitalization

Producción científica: Article › revisión exhaustiva

15 Citas (Scopus)

Idioma original	English
Páginas (desde-hasta)	1485-1489
Número de páginas	5
Publicación	Chest
Volumen	161
N.º	6
DOI	https://doi.org/10.1016/j.chest.2022.01.034
Estado	Published - jun 1 2022

Nota bibliográfica

Funding Information:
FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: T. S. V. reports research funding from the NIH, Agency for Healthcare Research and Quality (AHRQ), American Thoracic Society , and Society of Critical Care Medicine . I. D. P. reports research funding from the National Institutes of Health (NIH), Centers for Disease Control and Prevention , and Janssen Pharmaceuticals and funding to his institution from Asahi Kasei Pharma and Regeneron, all outside the present work. K. S. M. reports funding from the NIH and Roivant/Kinevant Sciences, outside of the submitted work. J. A. P. reports research funding from the NIH. K. C. V. is supported by resources from the VA Portland Health Care System. C. L. H. reports funding from the NIH and American Lung Association. None declared (A. S., S. E. J.)

Funding Information:
FUNDING/SUPPORT: This work was supported by the National Institutes of Health (NIH) [3U01HL123009-06S1, U01HL123009, U01HL122998, U01HL123018, U01HL123023, U01HL123008, U01HL123031, U01HL123004, U01HL123027, U01HL123010, U01HL123033, U01HL122989, U01HL123022, and U01HL123020]. The Research Electronic Data Capture data tools used in this study were supported, in part, by the NIH/ National Center for Advancing Translational Sciences [UL1TR000445]. T. S. V. was supported by the Agency for Healthcare Research and Quality (AHRQ) [R01HS028038] and the NIH [K23HL140165]. K. S. M. was supported by the NIH [K23HL130648]. C. L. H. was supported by the NIH [K24HL141526].

Financiación

FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: T. S. V. reports research funding from the NIH, Agency for Healthcare Research and Quality (AHRQ), American Thoracic Society , and Society of Critical Care Medicine . I. D. P. reports research funding from the National Institutes of Health (NIH), Centers for Disease Control and Prevention , and Janssen Pharmaceuticals and funding to his institution from Asahi Kasei Pharma and Regeneron, all outside the present work. K. S. M. reports funding from the NIH and Roivant/Kinevant Sciences, outside of the submitted work. J. A. P. reports research funding from the NIH. K. C. V. is supported by resources from the VA Portland Health Care System. C. L. H. reports funding from the NIH and American Lung Association. None declared (A. S., S. E. J.) FUNDING/SUPPORT: This work was supported by the National Institutes of Health (NIH) [3U01HL123009-06S1, U01HL123009, U01HL122998, U01HL123018, U01HL123023, U01HL123008, U01HL123031, U01HL123004, U01HL123027, U01HL123010, U01HL123033, U01HL122989, U01HL123022, and U01HL123020]. The Research Electronic Data Capture data tools used in this study were supported, in part, by the NIH/ National Center for Advancing Translational Sciences [UL1TR000445]. T. S. V. was supported by the Agency for Healthcare Research and Quality (AHRQ) [R01HS028038] and the NIH [K23HL140165]. K. S. M. was supported by the NIH [K23HL130648]. C. L. H. was supported by the NIH [K24HL141526].

Financiadores	Número del financiador
Asahi Kasei Pharma
VA Portland Health Care System
National Institutes of Health (NIH)	U01HL122998, U01HL123008, U01HL122989, U01HL123010, U01HL123020, U01HL123031, U01HL123023, U01HL123022, U01HL123033, U01HL123027, U01HL123004, U01HL123018
Centers for Disease Control and Prevention
National Heart, Lung, and Blood Institute (NHLBI)	U01HL123009
Agency for Healthcare Research and Quality	R01HS028038, K24HL141526, K23HL130648, K23HL140165
American Thoracic Society
American Lung Association
National Center for Advancing Translational Sciences (NCATS)	UL1TR000445
Society of Critical Care Medicine
Janssen Pharmaceuticals

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine
Critical Care and Intensive Care Medicine
Cardiology and Cardiovascular Medicine

Acceder al documento

10.1016/j.chest.2022.01.034

Otros archivos y enlaces

Citar esto

@article{3b9bbbdcf8ea4d998b9bad0d73bffcd4,

title = "Organization of Outpatient Care After COVID-19 Hospitalization",

author = "Valley, \{Thomas S.\} and Amanda Schutz and Peltan, \{Ithan D.\} and Vranas, \{Kelly C.\} and Mathews, \{Kusum S.\} and Jolley, \{Sarah E.\} and Palakshappa, \{Jessica A.\} and Hough, \{Catherine L.\} and Steingrub, \{Jay S.\} and Tidswell, \{Mark A.\} and Kozikowski, \{Lori Ann\} and Cynthia Kardos and Lesley DeSouza and Baron, \{Rebecca M.\} and Mayra Pinilla-Vera and Rubins, \{David M.\} and Antonio Arciniegas and Richard Riker and Christine Lord and Elie, \{Marie Carmelle\} and Daniel Talmor and Nathan Shapiro and Valerie Banner-Goodspeed and Hibbert, \{Kathryn A.\} and Kelsey Brait and Natalie Pulido and Alan Jones and James Galbraith and Utsav Nandi and Rebekah Peacock and Jenna Davis and Matthew Prekker and Michael Puskarich and Seth Jones and Anne Roerhl and Audrey Hendrickson and Michael Matthay and Kirsten Kangelaris and Kathleen Liu and Kimberly Yee and Hanjing Zhuo and Gregory Hendey and Steven Chang and Nida Qadir and Andrea Tam and Rebecca Beutler and Trisha Agarwal and Joseph Levitt and Jamie Sturgill and Kirby Mayer",

note = "Funding Information: FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: T. S. V. reports research funding from the NIH, Agency for Healthcare Research and Quality (AHRQ), American Thoracic Society , and Society of Critical Care Medicine . I. D. P. reports research funding from the National Institutes of Health (NIH), Centers for Disease Control and Prevention , and Janssen Pharmaceuticals and funding to his institution from Asahi Kasei Pharma and Regeneron, all outside the present work. K. S. M. reports funding from the NIH and Roivant/Kinevant Sciences, outside of the submitted work. J. A. P. reports research funding from the NIH. K. C. V. is supported by resources from the VA Portland Health Care System. C. L. H. reports funding from the NIH and American Lung Association. None declared (A. S., S. E. J.) Funding Information: FUNDING/SUPPORT: This work was supported by the National Institutes of Health (NIH) [3U01HL123009-06S1, U01HL123009, U01HL122998, U01HL123018, U01HL123023, U01HL123008, U01HL123031, U01HL123004, U01HL123027, U01HL123010, U01HL123033, U01HL122989, U01HL123022, and U01HL123020]. The Research Electronic Data Capture data tools used in this study were supported, in part, by the NIH/ National Center for Advancing Translational Sciences [UL1TR000445]. T. S. V. was supported by the Agency for Healthcare Research and Quality (AHRQ) [R01HS028038] and the NIH [K23HL140165]. K. S. M. was supported by the NIH [K23HL130648]. C. L. H. was supported by the NIH [K24HL141526]. ",

year = "2022",

month = jun,

day = "1",

doi = "10.1016/j.chest.2022.01.034",

language = "English",

volume = "161",

pages = "1485--1489",

number = "6",

}

TY - JOUR

T1 - Organization of Outpatient Care After COVID-19 Hospitalization

AU - Valley, Thomas S.

AU - Schutz, Amanda

AU - Peltan, Ithan D.

AU - Vranas, Kelly C.

AU - Mathews, Kusum S.

AU - Jolley, Sarah E.

AU - Palakshappa, Jessica A.

AU - Hough, Catherine L.

AU - Steingrub, Jay S.

AU - Tidswell, Mark A.

AU - Kozikowski, Lori Ann

AU - Kardos, Cynthia

AU - DeSouza, Lesley

AU - Baron, Rebecca M.

AU - Pinilla-Vera, Mayra

AU - Rubins, David M.

AU - Arciniegas, Antonio

AU - Riker, Richard

AU - Lord, Christine

AU - Elie, Marie Carmelle

AU - Talmor, Daniel

AU - Shapiro, Nathan

AU - Banner-Goodspeed, Valerie

AU - Hibbert, Kathryn A.

AU - Brait, Kelsey

AU - Pulido, Natalie

AU - Jones, Alan

AU - Galbraith, James

AU - Nandi, Utsav

AU - Peacock, Rebekah

AU - Davis, Jenna

AU - Prekker, Matthew

AU - Puskarich, Michael

AU - Jones, Seth

AU - Roerhl, Anne

AU - Hendrickson, Audrey

AU - Matthay, Michael

AU - Kangelaris, Kirsten

AU - Liu, Kathleen

AU - Yee, Kimberly

AU - Zhuo, Hanjing

AU - Hendey, Gregory

AU - Chang, Steven

AU - Qadir, Nida

AU - Tam, Andrea

AU - Beutler, Rebecca

AU - Agarwal, Trisha

AU - Levitt, Joseph

AU - Sturgill, Jamie

AU - Mayer, Kirby

N1 - Funding Information: FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: T. S. V. reports research funding from the NIH, Agency for Healthcare Research and Quality (AHRQ), American Thoracic Society , and Society of Critical Care Medicine . I. D. P. reports research funding from the National Institutes of Health (NIH), Centers for Disease Control and Prevention , and Janssen Pharmaceuticals and funding to his institution from Asahi Kasei Pharma and Regeneron, all outside the present work. K. S. M. reports funding from the NIH and Roivant/Kinevant Sciences, outside of the submitted work. J. A. P. reports research funding from the NIH. K. C. V. is supported by resources from the VA Portland Health Care System. C. L. H. reports funding from the NIH and American Lung Association. None declared (A. S., S. E. J.) Funding Information: FUNDING/SUPPORT: This work was supported by the National Institutes of Health (NIH) [3U01HL123009-06S1, U01HL123009, U01HL122998, U01HL123018, U01HL123023, U01HL123008, U01HL123031, U01HL123004, U01HL123027, U01HL123010, U01HL123033, U01HL122989, U01HL123022, and U01HL123020]. The Research Electronic Data Capture data tools used in this study were supported, in part, by the NIH/ National Center for Advancing Translational Sciences [UL1TR000445]. T. S. V. was supported by the Agency for Healthcare Research and Quality (AHRQ) [R01HS028038] and the NIH [K23HL140165]. K. S. M. was supported by the NIH [K23HL130648]. C. L. H. was supported by the NIH [K24HL141526].

PY - 2022/6/1

Y1 - 2022/6/1

UR - https://www.scopus.com/pages/publications/85130335031

UR - https://www.scopus.com/pages/publications/85130335031#tab=citedBy

U2 - 10.1016/j.chest.2022.01.034

DO - 10.1016/j.chest.2022.01.034

M3 - Article

C2 - 35108571

AN - SCOPUS:85130335031

SN - 0012-3692

VL - 161

SP - 1485

EP - 1489

JO - Chest

JF - Chest

IS - 6

ER -

Organization of Outpatient Care After COVID-19 Hospitalization

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto